Editas Medicine
EDIT
NASDAQ
IPO2016
about EDIT
Editas Medicine is a biotechnology company pioneering innovative gene-editing therapies using CRISPR technology to address a wide range of diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $2.59 | $2.59 | $2.33 | $222.10M | 3.16M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.63 | n/a | 59.92 | -1440.58% | -1487.84% | 0% |